Dual 177Lu-Prostate-Specific Membrane Antigen and 177Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation

被引：1
|
作者：
Beyhan, Ediz [1 ,2 ]
Fenercioglu, Ozge Erol [1 ]
Sahin, Rahime [1 ]
Cermik, Tevfik Fikret [1 ]
Ergul, Nurhan [1 ]
机构：
[1] Istanbul Training & Res Hosp, Clin Nucl Med, Istanbul, Turkiye
[2] Istanbul Training & Res Hosp, Clin Nucl Med, Kasap Ilyas Mah Org Abdurrahman NafizGurman Cd, TR-34098 Istanbul, Turkiye
来源：
CLINICAL NUCLEAR MEDICINE | 2024年 / 49卷 / 05期
关键词：
Ga-68-DOTATATE; Ga-68-PSMA; Lu-177; PET/CT; prostate cancer; LU-177-PSMA; GA-68-PSMA; PATIENT;
D O I：
10.1097/RLU.0000000000005131
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We present an 87-year-old man diagnosed with prostate cancer and neuroendocrine differentiation, posttherapy results to consecutive Lu-177-prostate-specific membrane antigen and( 177)Lu-DOTATATE. Despite hormonal therapy and chemoradiotherapy, the patient progressed rapidly, and multiple liver and bone metastases showed regression after Lu-177-prostate-specific membrane antigen and Lu-177-DOTATATE treatment. Prostate cancer with neuroendocrine differentiation is resistant to treatments; however, treatment with the combination of Lu-177-DOTATATE therapy may be promising.
引用
收藏
页码：447 / 448
页数：2
相关论文
共 50 条
  • [1] 177Lu-PSMA and 177Lu-DOTATATE Therapy in a Patient With Metastatic Castration-Resistant Prostate Cancer and Neuroendocrine Differentiation
    Assadi, Majid
    Pirayesh, Elahe
    Rekabpour, Seyed Javad
    Zohrabi, Farshad
    Jafari, Esmail
    Nabipour, Iraj
    Esmaili, Abdolhamid
    Amini, Abdullatif
    Ahmadzadehfar, Hojjat
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (12) : 978 - 980
  • [2] 177Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer
    Parihar, Ashwin Singh
    Hofman, Michael S.
    Iravani, Amir
    [J]. RADIOLOGY, 2023, 306 (02)
  • [3] Excellent Response to 177Lu-DOTATATE Peptide Receptor Radionuclide Therapy in a Patient With Progressive Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation After 177Lu-PSMA Therapy
    Liu, Chen
    Liu, Teli
    Zhang, Jingjing
    Baum, Richard P.
    Yang, Zhi
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (11) : 876 - 878
  • [4] 177Lu-DOTATATE Therapy in a Case of Castrate-Resistant Prostate Cancer With Neuroendocrine Differentiation
    Shu, Qiaoqiao
    Li, Xianjun
    Chen, Xi
    Chen, Yue
    Cai, Liang
    [J]. CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : E371 - E373
  • [5] Whole-Body 177Lu-Prostate-Specific Membrane Antigen Scan Pattern With Excess Free 177Lu-Chloride in a Metastatic Castration-Resistant Prostate Cancer Patient
    Askari, Emran
    Moghadam, Soroush Zarehparvar
    Divband, Ghasemali
    Aryana, Kamran
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (10) : 805 - 807
  • [6] The Therapeutic Efficacy and Safety of 177Lu-Prostate-Specific Membrane Antigen Radionuclide Therapy for Elderly Patients with Metastatic Castration Resistant Prostate Cancer
    Sahin, E.
    Elboga, U.
    Cayirli, Y. B.
    Cimen, U.
    Mumcu, V.
    Okuyan, M.
    Ekinci, E.
    Celen, Y. Z.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S399 - S400
  • [7] Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA A Chance for 177Lu-DOTATATE Therapy?
    Nesari Javan, Farnaz
    Aryana, Kamran
    Askari, Emran
    [J]. CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : E480 - E482
  • [8] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    [J]. BIOMEDICINES, 2021, 9 (04)
  • [9] 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
    Baum, Richard P.
    Kulkarni, Harshad R.
    Schuchardt, Christiane
    Singh, Aviral
    Wirtz, Martina
    Wiessalla, Stefan
    Schottelius, Margret
    Mueller, Dirk
    Klette, Ingo
    Wester, Hans-Juergen
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (07) : 1006 - 1013
  • [10] Unraveling the Hypocalcemic Response to 177Lu-Prostate-Specific Membrane Antigen Therapy
    Chiesa, Carlo
    Bagnalasta, Matteo
    Maccauro, Marco
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (02) : 332 - 333
12345